To evaluate diagnostic efficacy of maternal serum C - reactive protein to predict preterm labour

Kavita Gahlot, Kiran Pandey, Punya P. Singh, Vikash Gahlot, Rajesh Mourya


Background: Preterm birth is a major challenges faced by obstetricians worldwide. Globally, an estimated 13 million babies are born before 37 completed weeks of gestation annually. Preterm birth is the leading direct cause of neonatal death (27%); more than one million preterm newborns die annually. According to report ‘India is among the top 10 countries that account for 60 per cent of the world’s preterm births. Methods to detect preterm labour early include ultrasound examination of the cervix and detection of biochemical markers of preterm labour in blood (include serum C - reactive protein level) and cervicovaginal secretions. The objective of the study was evaluate diagnostic efficacy of maternal serum C - reactive protein (CRP) to predict preterm labour.

Methods: A prospective study comprised of a total of 132 pregnant women with singleton fetus with symptoms of preterm labour. Serum CRP values was taken in all patients. Out of which 17 patients were lost during follow up, 3 patients develop PPROM. Hence study was conducted over 112 patients. Among these 62 patients went in preterm labour and 50 patients delivered at term.

Results: For predicting preterm delivery sensitivity, specificity, positive and negative predictive value for serum CRP were 70.9%, 70%, 74.5% and 66% respectively.

Conclusions: Serum CRP is good predictor to differentiate the women who were likely to deliver preterm. CRP positivity in early pregnancy is associated with nearly a twofold increased risk of preterm delivery.


Preterm labor, Prospective study, Serum CRP

Full Text:



Lawn JE, Gravett MG, Nunes TM. The GAPPS Review Group BMC Pregnancy and Childbirth. 2010;10(Suppl 1):S1

Yeast JD, Lu G. Biochemical markers for the prediction of preterm labor. Obstet Gynecol Clin North Am. 2005;32:369-81.

Hilier SL, Nugent RP, Esenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low birth weight infant. N Eng J Med. 1995:333:1737-42.

Goepfert AR, Goldenberg RL. Prediction of prematurity. Curr Opin Obstet Gynecol. 1996;8:417-27.

Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med. 1999;27:5-20.

Tillet S, Francis T Jr. Serological reactions in pneumonia with a non protein somatic fraction of pneumococcus. J Exp Med. 1930;52:561-71.

Mortensen RF, Osmand AP, Gewurz H. Effect of c reactive protein in the lymphoid system. I. binding to thymus dependent lymphocytes and alteration of their functions. J Exp Med. 1975;141:824-39.

Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1:653-7.

Mortensen RF, Osmand AP, Lint TF, Gewurz H. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. J Immunol. 1976;117:774-81.

Whitehead AS, Bruns GAP, Markham AF, et al. Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome-1. Science. 1983;221:69-71.

Fied BA, Gewurz H. Effect of C reactive protein on Platelet Function. I. Inhibition of platelet aggregation and release reactions. J Immunol. 1976;116:1289-94.

Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C- reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol. 1974;112:2135-47.

Hilier SL, Nugent RP, Esenbach DA. Association between bacterial vaginosis and preterm delivery of a low birth weight infant. N Eng J Med. 1995:333:1737-42.

Watts DH, Krohn MA, Wener MH, et al. C-reactive protein in normal pregnancy. Obstet Gynecol. 1991;77:176-80.

Lohsoonthorn V, Qiu C, Williams MA. Maternal serum C-reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. ClinBiochem. 2007;40(5-6):330-5.

Hvilsom GB, Thorsen P, Jeune B. C-reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand. 2002;81:424-9.

Ghezzi F, Franchi M, Raio L. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. J Obstet Gynecol. 2002;186:268-73.